Infinovo was formed in 2016. For the past few years, Infinovo has been focusing on developing an Accurate and Affordable CGM for patients which will be available for both Type 1 and Type 2 Diabetics.
Our World Class Engineers have developed a CGM which can compete in the Global Market for accuracy, durability and design.
The Glunovo i3 CGM is the first-generation CGM product from Infinovo, which received CE Certification in June 2019 and in the coming months will be available in the European Market.
Company’s Keywords:
cgm & diabetes management
<13
<1900000
<2016